drugset / Trial / NCT00244543
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to establish the efficacy of R89674 0.25% ophthalmic solution compared with placebo in alleviating the signs and symptoms of conjunctival allergen challenge-induced allergic conjunctivitis
Timeline
- Start
- 2005-10
- Primary completion
- 2005-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcaftadine | Small molecule | 0.25 % | Other |